UPDATED: Boehringer’s Hernexeos Broadens Indication With Commissioner’s Priority Voucher Approval

 
• By Sue Sutter
  
Race track
Hernexeos' supplemental indication had a speedy review under the CNPV program. (Shutterstock)
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Review Pathways

More from United States